Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Cocrystal Pharma stock

Learn how to easily invest in Cocrystal Pharma stock.

Cocrystal Pharma Inc is a biotechnology business based in the US. Cocrystal Pharma shares (COCP) are listed on the NASDAQ and all prices are listed in US Dollars. Cocrystal Pharma employs 13 staff and has a trailing 12-month revenue of around $510,000.

How to buy shares in Cocrystal Pharma

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – COCP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Cocrystal Pharma stock price (NASDAQ: COCP)

Use our graph to track the performance of COCP stocks over time.

Cocrystal Pharma shares at a glance

Information last updated 2022-09-25.
Latest market close$0.28
52-week range$0.27 - $1.08
50-day moving average $0.40
200-day moving average $0.49
Wall St. target price$4.08
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.17

Buy Cocrystal Pharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cocrystal Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cocrystal Pharma price performance over time

Historical closes compared with the close of $0.2802 from 2022-09-27

1 week (2022-09-22) -3.38%
1 month (2022-08-29) -33.29%
3 months (2022-06-29) -30.14%
6 months (2022-03-28) -50.84%
1 year (2021-09-29) -72.53%
2 years (2020-09-29) -69.87%
3 years (2019-09-27) 2.03
5 years (2017-09-28) 0.07%

Cocrystal Pharma financials

Revenue TTM $510,000
Gross profit TTM $-8,794,000
Return on assets TTM -13.95%
Return on equity TTM -54.07%
Profit margin 0%
Book value $0.51
Market capitalisation $26.7 million

TTM: trailing 12 months

Cocrystal Pharma share dividends

We're not expecting Cocrystal Pharma to pay a dividend over the next 12 months.

Have Cocrystal Pharma's shares ever split?

Cocrystal Pharma's shares were split on a 1:30 basis on 23 January 2018. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cocrystal Pharma shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Cocrystal Pharma shares which in turn could have impacted Cocrystal Pharma's share price.

Cocrystal Pharma share price volatility

Over the last 12 months, Cocrystal Pharma's shares have ranged in value from as little as $0.27 up to $1.08. A popular way to gauge a stock's volatility is its "beta".

COCP.US volatility(beta: 0.72)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cocrystal Pharma's is 0.7231. This would suggest that Cocrystal Pharma's shares are less volatile than average (for this exchange).

Cocrystal Pharma overview

Cocrystal Pharma, Inc. , a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that is in preclinical development trials for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp.

Frequently asked questions

What percentage of Cocrystal Pharma is owned by insiders or institutions?
Currently 15.889% of Cocrystal Pharma shares are held by insiders and 21.273% by institutions.
How many people work for Cocrystal Pharma?
Latest data suggests 13 work at Cocrystal Pharma.
When does the fiscal year end for Cocrystal Pharma?
Cocrystal Pharma's fiscal year ends in December.
Where is Cocrystal Pharma based?
Cocrystal Pharma's address is: 19805 North Creek Parkway, Bothell, WA, United States, 98011
What is Cocrystal Pharma's ISIN number?
Cocrystal Pharma's international securities identification number is: US19188J3005
What is Cocrystal Pharma's CUSIP number?
Cocrystal Pharma's Committee on Uniform Securities Identification Procedures number is: 09072E103

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site